Search research articles
Contact Us
Filters
Showing results (171-180 of 304) with videos related to
Page
of 31
Sort By:
Proteomics
|
December 7, 2002
Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance
Roland Kellner, Rudolf Lichtenfels, Derek Atkins, et al.
Cancer Immunology, Immunotherapy : CII
|
October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Barbara Seliger, Robert Stoehr, Diana Handke, et al.
Oncotarget
|
October 22, 2015
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
Franziska Stehle, Sandra Leisz, Kristin Schulz, et al.
Oncoimmunology
|
March 5, 2016
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
Emilia Andersson, Isabel Poschke, Lisa Villabona, et al.
European Journal of Medicinal Chemistry
|
December 3, 2014
Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens
Claudia Bobach, Stephanie Tennstedt, Kristin Palberg, et al.
Cancer Immunology, Immunotherapy : CII
|
January 20, 2012
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer
Emilia Andersson, Lisa Villabona, Kjell Bergfeldt, et al.
Journal of Translational Medicine
|
November 13, 2025
Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer
Mario Udinotti, Udo Siebolts, Marcus Bauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 6, 2024
Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival
Julia Ohlinger, Dirk Vordermark, Christian Ostheimer, et al.
Oncotarget
|
July 14, 2016
Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization
André Steven, Sandra Leisz, Katharina Sychra, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2021
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
Yu Yao, Heng Liang, Xin Fang, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 304) with videos related to
Sort By:
Page
of 31
Proteomics
|
December 7, 2002
Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance
Roland Kellner, Rudolf Lichtenfels, Derek Atkins, et al.
Cancer Immunology, Immunotherapy : CII
|
October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Barbara Seliger, Robert Stoehr, Diana Handke, et al.
Oncotarget
|
October 22, 2015
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
Franziska Stehle, Sandra Leisz, Kristin Schulz, et al.
Oncoimmunology
|
March 5, 2016
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
Emilia Andersson, Isabel Poschke, Lisa Villabona, et al.
European Journal of Medicinal Chemistry
|
December 3, 2014
Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens
Claudia Bobach, Stephanie Tennstedt, Kristin Palberg, et al.
Cancer Immunology, Immunotherapy : CII
|
January 20, 2012
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer
Emilia Andersson, Lisa Villabona, Kjell Bergfeldt, et al.
Journal of Translational Medicine
|
November 13, 2025
Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer
Mario Udinotti, Udo Siebolts, Marcus Bauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 6, 2024
Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival
Julia Ohlinger, Dirk Vordermark, Christian Ostheimer, et al.
Oncotarget
|
July 14, 2016
Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization
André Steven, Sandra Leisz, Katharina Sychra, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2021
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
Yu Yao, Heng Liang, Xin Fang, et al.
Page
of 31